Literature DB >> 16996897

Functional status and quality of life in chronic obstructive pulmonary disease.

Jane Z Reardon1, Suzanne C Lareau, Richard ZuWallack.   

Abstract

Exertional dyspnea often causes patients with chronic obstructive pulmonary disease (COPD) to unconsciously reduce their activities of daily living (ADLs) to reduce the intensity of their distress. The reduction in ADLs leads to deconditioning which, in turn, further increases dyspnea. Both dyspnea and fatigue are important factors affecting health-related quality of life (HRQOL). The functional status of patients relates to how well they perform ADLs. Activities, however, may not be severely limited until the disease becomes advanced. The elimination of an ADL depends on the necessity or desirability of that activity and the intensity of the associated symptoms. HRQOL is measured using symptoms, functional status, and a rating of their impact on the individual. The Pulmonary Functional Status Scale (PFSS) and the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ) are 2 COPD-specific functional status questionnaires. Pedometers or accelerometers can quantify the levels of activity of patients with COPD. HRQOL is measured with validated multidimensional questionnaires that cover symptoms, physical, psychological, and social domains. Ideally, these instruments are discriminative (i.e., separate degrees of impairment) and evaluative (i.e., detect small changes after therapy). HRQOL questionnaires may be generic (e.g., Medical Outcomes Study Short Form-36 [SF-36]) and can measure favorable changes after intervention, such as pulmonary rehabilitation, or they can be disease specific with disease-related domains, e.g., Chronic Respiratory Disease Questionnaire (CRQ) with domains of dyspnea, fatigue, emotion, and mastery; and St. George's Respiratory Questionnaire (SGRQ) with domains of symptoms, activity, and psychosocial impact. A case is presented that depicts how these tools may be used to evaluate improvement with intervention in a patient with COPD.

Entities:  

Mesh:

Year:  2006        PMID: 16996897     DOI: 10.1016/j.amjmed.2006.08.005

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  50 in total

1.  Cognitive and Perceptual Factors, Not Disease Severity, Are Linked with Anxiety in COPD: Results from a Cross-Sectional Study.

Authors:  Elyse R Thakur; Shubhada Sansgiry; Nancy J Petersen; Melinda Stanley; Mark E Kunik; Aanand D Naik; Jeffrey A Cully
Journal:  Int J Behav Med       Date:  2018-02

Review 2.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

3.  Strengthening the Case for Cluster Set Resistance Training in Aged and Clinical Settings: Emerging Evidence, Proposed Benefits and Suggestions.

Authors:  Christopher Latella; Carolyn Peddle-McIntyre; Lauren Marcotte; James Steele; Kristina Kendall; Ciaran M Fairman
Journal:  Sports Med       Date:  2021-05-13       Impact factor: 11.136

Review 4.  Management of refractory breathlessness in patients with advanced cancer.

Authors:  Steffen T Simon; Claudia Bausewein
Journal:  Wien Med Wochenschr       Date:  2009-12

5.  Implantation of fibrin gel on mouse lung to study lung-specific angiogenesis.

Authors:  Tadanori Mammoto; Akiko Mammoto
Journal:  J Vis Exp       Date:  2014-12-21       Impact factor: 1.355

6.  Identification of Anxiety Symptom Clusters in Patients with COPD: Implications for Assessment and Treatment.

Authors:  Jessica Y Breland; Natalie E Hundt; Terri L Barrera; Joseph Mignogna; Nancy J Petersen; Melinda A Stanley; Jeffery A Cully
Journal:  Int J Behav Med       Date:  2015-10

7.  HIV and COPD: impact of risk behaviors and diseases on quality of life.

Authors:  M Bradley Drummond; Gregory D Kirk; Meredith C McCormack; Mariah M Marshall; Erin P Ricketts; Shruti H Mehta; Robert A Wise; Christian A Merlo
Journal:  Qual Life Res       Date:  2010-07-09       Impact factor: 4.147

Review 8.  What Does the TOVITO Programme Tell Us about How We Can Manage COPD?

Authors:  Richard E K Russell
Journal:  Turk Thorac J       Date:  2018-10-01

9.  New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jennifer S Albrecht; Ting-Ying Huang; Yujin Park; Patricia Langenberg; Ilene Harris; Giora Netzer; Susan W Lehmann; Bilal Khokhar; Linda Simoni-Wastila
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-18       Impact factor: 3.485

10.  Does the COPD assessment test reflect functional status in patients with COPD?

Authors:  Aline Almeida Gulart; Anelise Bauer Munari; Ana Paula Adriano de Queiroz; Katerine Cristhine Cani; Darlan Laurício Matte; Anamaria Fleig Mayer
Journal:  Chron Respir Dis       Date:  2016-08-20       Impact factor: 2.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.